Relapsed platinum-sensitive Ovarian cancer
Also known as: Platinum-sensitive Relapsed Ovarian Cancer / Platinum Sensitive Relapsed Ovarian Cancer / Relapsed Platinum Sensitive Ovarian Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB05109 | Trabectedin | An alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma). |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB05109 | Trabectedin | Cytochrome P450 3A4 | enzyme |
| DB05109 | Trabectedin | Cytochrome P450 2C9 | enzyme |
| DB05109 | Trabectedin | Cytochrome P450 2D6 | enzyme |
| DB05109 | Trabectedin | Cytochrome P450 2E1 | enzyme |
| DB05109 | Trabectedin | Cytochrome P450 2C19 | enzyme |
| DB05109 | Trabectedin | DNA | target |
| DB05109 | Trabectedin | Prostaglandin G/H synthase 1 | enzyme |